Bilski in the boardroom

This is an Insight article, written by a selected partner as part of IAM's co-published content. Read more on Insight

In a ruling that could significantly affect patent portfolio value, the US Supreme Court will soon decide whether software, biotech and IP processes require a special purpose machine to be eligible for patent

Download
 

Unlock unlimited access to all IAM content